Ozempic is not FDA-approved for weight loss. It’s approved for managing type 2 diabetes and reducing cardiovascular risk in adults with diabetes. However, doctors can and do prescribe it off-label for weight loss, and its active ingredient (semaglutide) is the same one found in Wegovy, which is specifically approved for weight management. Getting a prescription means understanding what doctors look for, what insurance will cover, and what alternatives exist if Ozempic isn’t the right fit.
Why Ozempic Works for Weight Loss
Semaglutide mimics a natural gut hormone called GLP-1 that plays a central role in appetite regulation. When you take Ozempic, it activates receptors in the parts of your brain that control hunger and fullness, reducing how hungry you feel throughout the day. It also slows the rate at which food leaves your stomach, so meals keep you feeling satisfied for longer. The combination of less hunger and prolonged fullness leads most people to eat significantly fewer calories without white-knuckling through constant cravings.
Ozempic vs. Wegovy: A Key Distinction
Both medications contain semaglutide and come from the same manufacturer. The difference is their approved use. Wegovy is FDA-approved for weight management in adults and children 12 and older. It’s also approved for reducing cardiovascular risk in adults with obesity and heart disease. Ozempic is approved only for type 2 diabetes and related cardiovascular and kidney complications.
This distinction matters because insurance companies use FDA-approved indications to decide what they’ll cover. If you don’t have type 2 diabetes, your insurer is unlikely to cover Ozempic. Many doctors who want to prescribe semaglutide for weight loss will write a prescription for Wegovy instead, since that’s the version designed and approved for that purpose. If Wegovy is unavailable or too expensive, some providers will prescribe Ozempic off-label, which is legal and common in medicine, but it can create coverage headaches.
What Doctors and Insurers Look For
Whether your provider prescribes Wegovy or Ozempic off-label, the medical criteria are similar. Based on standard insurance requirements like those from UnitedHealthcare, you typically need to meet one of these thresholds:
- BMI of 30 or higher, which qualifies on its own
- BMI of 27 or higher combined with at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea
Beyond the BMI number, most insurers require that you’re already participating in lifestyle modifications. That means some combination of dietary changes, exercise, or a behavioral support program. You don’t need to have completed a months-long program before your first appointment, but you should be actively working on diet and exercise and be prepared to discuss what you’ve tried.
For reauthorization after the initial prescription period, insurers typically want to see at least 5% loss of your baseline body weight. If you started at 220 pounds, that means losing 11 pounds or more to keep your coverage going.
Steps to Get a Prescription
Start with your primary care doctor or find a provider who specializes in weight management. Obesity medicine specialists, endocrinologists, and increasingly telehealth platforms all prescribe these medications. At your appointment, come prepared to discuss your weight history, what you’ve already tried (diets, exercise programs, previous medications), and any weight-related health conditions you have. Your doctor will check your BMI, review your medical history, and determine if semaglutide is appropriate.
If you have type 2 diabetes, your doctor can prescribe Ozempic on-label and insurance coverage is more straightforward. If you don’t have diabetes and your goal is purely weight loss, your doctor will likely prescribe Wegovy instead. Either way, most insurance plans require prior authorization, which means your doctor’s office submits paperwork to your insurer explaining why the medication is medically necessary. This process can take a few days to a few weeks.
If your insurance denies coverage, your doctor can file an appeal. Having documented evidence of failed weight-loss attempts, lab work showing metabolic problems, and records of lifestyle modification efforts strengthens the case.
What the Dosing Schedule Looks Like
Ozempic is a once-weekly injection given under the skin, typically in the abdomen, thigh, or upper arm. The dosing starts low and increases gradually to reduce side effects, especially nausea.
You’ll begin at 0.25 mg per week for the first four weeks. This starting dose isn’t strong enough to control blood sugar or drive significant weight loss on its own. It’s designed to let your body adjust. After four weeks, the dose increases to 0.5 mg weekly. If more effect is needed, your doctor may increase it to 1 mg weekly after at least another four weeks at the lower dose. An oral tablet form is also available, with its own titration schedule starting at 1.5 mg daily.
Who Should Not Take Ozempic
Ozempic is contraindicated if you or a family member has a history of medullary thyroid carcinoma (a specific type of thyroid cancer) or a condition called Multiple Endocrine Neoplasia syndrome type 2. These are rare but serious conditions, and your doctor will ask about them before prescribing. The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These tend to be worst during dose increases and often improve over time.
What It Costs Without and With Insurance
Ozempic is expensive at full price. For the injectable pen, new patients without insurance pay $199 per month for the first two months at the starting doses. After that, existing patients pay $349 per month for the 0.25 mg, 0.5 mg, or 1 mg pens, and $499 per month for the 2 mg pen. The oral tablet ranges from $149 to $299 per month depending on the dose and whether you’re a new or existing patient.
If you have commercial insurance that covers Ozempic, the manufacturer’s savings card can bring your copay down to as little as $25 per month, with up to $100 in monthly savings for up to 48 months. People on Medicare, Medicaid, or other government programs are not eligible for the savings card.
Novo Nordisk also runs a Patient Assistance Program for people who meet specific income requirements and have no prescription drug coverage through government programs. If you’re uninsured, this is worth exploring directly through NovoCare. Medicare Part D beneficiaries are excluded from this program.
If You Can’t Get Ozempic
Supply shortages and insurance denials have been persistent issues with both Ozempic and Wegovy. If you can’t access either, there are alternatives. Tirzepatide (sold as Zepbound for weight loss and Mounjaro for diabetes) works on two gut hormone receptors instead of one and has shown strong weight-loss results in clinical trials. Older options like orlistat and phentermine-topiramate are less effective but more widely available and often cheaper. Your doctor can help identify which option fits your situation, insurance, and health profile.